In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.

In vitro activities of the new macrolides clarithromycin, previously designated A-56268 (TE-031), and A-63075 and of the aryl-fluoroquinolones difloxacin (A-56619) and temafloxacin (A-62254) against 14 strains of Mycoplasma pneumoniae, 20 strains of Mycoplasma hominis, and 28 strains of Ureaplasma u...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Waites, K B, Cassell, G H, Canupp, K C, Fernandes, P B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC175906/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2973283/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.10.1500
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!